Emanuela Taioli, MD, PhD
- DIRECTOR, INSTITUTE FOR TRANSLATIONAL EPIDEMIOLOGY
- PROFESSOR | Population Health Science and Policy
- PROFESSOR | Thoracic Surgery
Research Topics:Biostatistics, Cancer, Epidemiology, Healthcare, Lung, Obesity, Personalized Medicine, Public Health, Thyroid, Translational Research
Dr. Emanuela Taioli received her M.D. from University of Milan in 1981. She then attended Columbia University where she received her M.S. and Ph.D. degrees in Epidemiology.
In 2015 Dr. Taioli joined Mount Sinai as Professor of Population Health and Science and of Thoracic Surgery, and the Director of the Institute for Translational Epidemiology, and as Director of the Center for the Study of Thoracic Diseases Outcomes. She is also Associate Director for Population Science and a Co-Leader of the Cancer Prevention and Control Program at The Tisch Cancer Institute.
As Associate Director, Dr. Taioli oversees the epidemiological, behavioral and health service research activities of TCI’s multi-disciplinary faculty with a goal of securing designation of TCI as a National Cancer Institute (NCI)-Comprehensive Cancer Center – a level higher than the NCI Cancer Center designation that TCI obtained in 2015, reflecting an added depth and breadth of research as well as substantial transdisciplinary research.
Prior to joining the School, Dr. Taioli was the Chief of Epidemiology for the Northwell Health System at Hofstra School of Medicine. She established herself as a pioneer in pooling large datasets and establishing the first international pooled analysis of studies on gene-environment interaction, which lead to the formation of large consortia investigating cancer outcomes on an international level.
Among her most important contributions are those to the field of cancer prevention, including the study of cancer risk factors in healthy populations, cancer predisposing factors, hormone metabolism and genetic susceptibility to environmental exposure. She is a well-recognized expert in cancer survivorship and the effect of lifestyles changes on the risk for cancer recurrence and the development of new secondary cancers. Moreover, she has worked extensively on health disparities, access to care in minority populations, and chronic diseases prevention in the underserved.
MD, University of Milan
PhD, Columbia University School of Arts and Science
My research interest and expertise is in the area of cancer epidemiology. I have published widely on environmental carcinogens, cancer and nutrition, and genetic susceptibility to cancer. I am internationally known for my work in cancer prevention which includes the study of cancer risk factors in healthy populations, cancer predisposing factors, hormone metabolism and genetic susceptibility to environmental exposure; cancer survivorship and the effect of lifestyles changes on the risk for cancer recurrence and the development of new secondary cancers; health disparity, access to care in minorities, and chronic diseases prevention in the underserved. I am the Director of the Center for the Study of Thoracic Diseases Outcomes and in that capacity I work closely with surgeons, radiologists and immunologists on lung cancer early detection and treatment studies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Taioli during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Science Policy Institute
- American Cancer Society; Milliman; Shook Hardy & Bacon, L.L.P./Johnson and Johnson; Worrest Weldon law group
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.